Relaxin-2 does not ameliorate nephropathy in an experimental model of type-1 diabetes.
Dschietzig TB, Krause-Relle K, Hennequin M, von Websky K, Rahnenführer J, Ruppert J, Grön HJ, Armbruster FP, Bathgate RA, Aschenbach JR, Forssmann WG, Hocher B.
Dschietzig TB, et al.
Kidney Blood Press Res. 2015;40(1):77-88. doi: 10.1159/000368484.
Kidney Blood Press Res. 2015.
PMID: 25791819
Free article.